Real-world use of enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer previously treated with chemotherapy and immunotherapy: a multicenter, retrospective, non-interventional study in FranceFirst published 24/10/2023 Last updated 07/05/2025 EU PAS number: EUPAS105591StudyFinalised
Registration Department Clinical Trial clinicaltrialregistration@astellas.comStudy contactclinicaltrialregistration@astellas.com